Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02778971 · ClinicalTrials.gov registry record
Implications for Management of PET Amyloid Classification Technology
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 41
- Enrollment target
NCT02778971: Completed study, sponsored by University of Utah.
NCT02778971 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02778971 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The main purpose of this study is to explore the impact of an amyloid positron emission tomography and computed tomography (PET/CT) scan on physician diagnosis and management, including drug management and care practices, for patients with a diagnosis of cognitive impairment. This study also intends to capture specific patient-reported outcomes related to patient burden, confidence and satisfaction. The hypothesis is that to aid early diagnosis, individuals with a diagnostically uncertain etiology for their dementia will benefit from knowledge of amyloid plaque burden status, through an alteration of patient diagnosis and management, which will lead to significant changes in patient and care partner reported outcomes.
Primary Outcome
% of 13 care practices that differ before and after the amyloid PET scan
Interventions
- DRUG [18F]Flutemetamol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-06 |
| Est. Completion | 2022-09 |
What the finished NCT02778971 record still lists
NCT02778971 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which [18F]Flutemetamol is the first listed.
NCT02778971 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02778971 about?
NCT02778971 is a clinical study titled "Implications for Management of PET Amyloid Classification Technology". The main purpose of this study is to explore the impact of an amyloid positron emission tomography and computed tomography (PET/CT) scan on physician diagnosis and management, including drug management and care practices, for patients with a diagnosis of cognitive impairment. This study also intends...
What is the current status of trial NCT02778971?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2016-06. Estimated completion is 2022-09.
What interventions are being tested in trial NCT02778971?
The interventions under investigation include: [18F]Flutemetamol (DRUG).
Who is sponsoring clinical trial NCT02778971?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia